Given the limitations of anti-SSA antibody detection (delay and non-specificity) and labial salivary gland biopsy (invasiveness and subjectivity) in early pSS diagnosis, regulating the inflammatory response and employing anti-inflammatory therapy have emerged as crucial management strategies for pSS [10–12]. Here, CALR is linked to peeling skin syndrome.